INDI: The Rebound Is Real. The Cash Test Is Next.

The 60-second read

Five things to know

1. The core is accelerating. Core revenue reached $40.7M; the Q4 midpoint implies another 15.5% sequential increase to $47M.
2. Adjusted progress is not GAAP profit. Adjusted operating loss narrowed to $7.2M, but GAAP operating loss was $39.0M and the compensation add-back increased.
3. Cash consumption worsened. Nine-month operating cash outflow was $73.4M before $7.0M of property and equipment spending.
4. Ownership changes the valuation. Wuxi is consolidated despite only 34.38% equity ownership; a large part of its economics belongs to outside owners.
5. Neither deal is completed in the latest filing. The Wuxi stake sale and CMOS acquisition remain conditional, so future cash proceeds are not booked as cash today.

Three scenarios, one probability-weighted number

Conditional author values: notes remain debt for cash settlement; no Wuxi exchange; 250M shares is not full contingent dilution.

Signposts: what would change our mind

These are author checkpoints, not confirmed reporting dates or management commitments. Transaction effects must be reconciled before grading cash and revenue thresholds.

A rebound with a demanding cash test

indie Semiconductor closed November 6 at $1.81, up 33.6% from the preceding $1.355 close. That is a large response to the reported recovery and outlook. It is also one observation after a difficult period: the saved provider quote shows a 52-week range of $1.34 to $5.49. Neither the rebound nor the previous high determines intrinsic value. This is the first INDI episode found in the canonical local and exact-period publication records, so there is no prior Charged Alpha target or signpost score to manufacture.

Our call is SELL with conviction three out of five and very high uncertainty. This is a valuation judgment at the reference close, not a claim that the company's technologies lack value. Automotive sensing programs can create substantial future revenue, and the current core trajectory is stronger than the consolidated headline alone suggests. The issue is how much cash must be consumed before those programs become profitable, how many shares participate, and which consolidated earnings belong to outside owners.

The provider market capitalization is $394.451M. Multiplying $1.81 by our 250M economic-share assumption produces $452.5M instead. That difference is deliberate: the model includes ADK unit exchanges, paired with Class V voting shares and a dilution reserve rather than reusing the provider's quote share count. The quote remains valid market context; it is not the denominator for our valuation. Our modeled enterprise-value bridge therefore should not be mistaken for a vendor's standard EV field.

The historical reaction chart consistently compares each release-date close with the following trading-session close. The exact November 5 release clock remains unconfirmed, so we do not label it with a guessed time or substitute the earnings-call start. This fixed window is descriptive and does not isolate earnings from broader market, sector or company news. Daily-history prices can be rounded differently from the quote: the November 5 history close is $1.36 versus $1.355 in the quote comparison, so the historical reaction column is about 33.1% while the precise quote comparison is 33.6%.

Source: Saved quote, price history and earnings dates. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

Growth improved; the loss still matters

Third-quarter revenue was $70.241M, up 30.9% from $53.676M a year earlier and 9.7% from $64.009M in Q2. Product revenue was $67.491M and contract revenue $2.750M. Management highlighted $40.7M of core business revenue, up approximately 14% sequentially. The gap between consolidated revenue and this rounded core figure is approximately $29.541M; it should not be presented as an independently audited exact Wuxi segment measure.

The saved provider estimate was $70.211M revenue, essentially in line with the actual result. Adjusted loss per share of $0.05 was worse than the provider's $0.03851 loss estimate. These estimates were retrieved after the event and are not a separately frozen pre-announcement survey. Management's statement that revenue exceeded its own outlook midpoint can be true while the release is broadly in line with the retrieved Street revenue estimate. Each comparison needs its own denominator.

Q4 revenue guidance is $73M to $81M. At the $77M midpoint, management expects approximately $47M core revenue and $30M Wuxi revenue. The core midpoint is a computed 15.5% above Q3, while the company describes approximately 64% core growth from the year-earlier quarter. Adding the guidance range to reported nine-month revenue yields $262.707M to $270.707M for 2026. This arithmetic assumes the announced perimeter remains the basis of the outlook; closing a disposal would require a fresh bridge.

The company gives guidance on a non-GAAP basis and does not provide a complete GAAP outlook reconciliation because some future adjustments cannot be reasonably estimated. We do not convert the revenue guide into a promised EPS or cash-flow result. The key question for the next report is whether higher revenue requires proportionately more inventory, compensation and external financing, or begins to produce operating leverage that survives the reconciliation.

Source: Current release, outlook and reconciliations. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

The core and the ownership perimeter

indie has one operating and reportable segment. Its products span radar, computer vision, LiDAR, ultrasonic sensing and photonics, but the filing does not provide a standalone operating-profit series for every product family. We therefore show consolidated profit and clearly labeled core revenue disclosures instead of inventing product margins. A design win is evidence of a customer selection, not a recognized sale, binding volume guarantee or measured lifetime cash return.

The release reports more than forty vision design wins year to date, a radar-chipset selection by one of the top three North American manufacturers, and an in-cabin software program for an Australian-market vehicle with production starting in 2027. Those developments support the bull case that the portfolio is finding commercial applications. The counterweight is the long path from selection through qualification, vehicle production, unit volumes and actual cash collections. Customer program changes can alter that path even after a technology performs well.

Wuxi is consolidated because ADK held approximately 59% voting control, although it owned only 34.38% of the equity. Consolidation therefore brings in the subsidiary's full revenue and financial position while external shareholders retain a large economic interest. Treating all consolidated sales as if they belonged solely to INDI common shareholders would overstate the economic base. The separate Class V structure at the parent creates another denominator issue, which we address through economic shares rather than by confusing it with Wuxi ownership.

The proposed sale of the Wuxi stake is potentially helpful for funding and reporting clarity, but it also removes revenue and changes the balance sheet. A smaller post-sale company could have better cash economics; a larger reported company can still leave little residual value to public shareholders. Our current model keeps the existing consolidated perimeter, deducts an explicit external-owner valuation proxy, and adds no sale proceeds. It must be rebuilt on an actual closing balance sheet after a disposal.

Source: Notes 11–12, revenue and ownership; release business highlights. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

The compensation bridge absorbs the improvement

GAAP operating loss was $38.997M versus $38.342M a year earlier. Adjusted operating loss improved to $7.196M from $11.304M. Both statements are true because the reconciliation expanded. The current operating bridge adds back $24.294M of share-based compensation, $7.302M amortization and $0.205M acquisition-related professional expenses. The compensation add-back alone is 34.6% of revenue and increased from $18.985M in the comparable quarter.

The 10-Q's stock-compensation note reports $22.978M for the quarter, while the release's broader compensation adjustment is $24.294M. We retain both labels rather than silently making them equal. The release describes compensation adjustments that can include employer taxes and related items. Without a precise additional reconciliation, the $1.316M difference should remain a disclosed definition gap, not an invented allocation. Economic compensation matters regardless of whether it is paid in cash, issued shares or associated payroll costs.

Below operating income, interest income of $0.878M and a $4.320M contingent-consideration gain partly offset $4.721M interest expense and $0.851M other expense. The resulting pretax loss was $39.371M. A $0.535M tax provision led to a $39.906M consolidated net loss; allocating $1.123M of losses to noncontrolling interests left a $38.783M loss attributable to indie. Changes in contingent consideration are accounting marks, not recurring semiconductor customer receipts.

GAAP diluted loss per share was $0.18 using 219.304M weighted shares. The adjusted calculation uses 233.449M shares, including ADK units paired with Class V voting shares and certain unexercised acquisition options, then allocates adjusted Wuxi minority profit. Its $11.564M parent adjusted loss produces the rounded $0.05 loss. A smaller adjusted loss cannot be read as a simple one-step change in the GAAP numerator; the share count and minority allocation also change.

Source: Full GAAP / non-GAAP reconciliation; final 10-Q note 13. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

Nine earnings-quality checks

Revenue growth is the strongest part of the report, but working capital absorbed cash. Receivables increased to $79.272M from $57.485M at year end; inventory increased to $80.039M from $48.618M. Ending-balance proxies are 101.6 receivable days and 150.5 inventory days. They use ninety days and quarterly revenue or cost of goods sold, not average balances. The proxies are warnings to investigate timing and mix, not proof of collection problems or obsolete inventory.

The issuer explicitly does not report a GAAP gross-profit or gross-margin measure because certain contract-related costs are included in research and development and cannot practicably be split. Revenue less reported cost of goods sold is $22.367M, but labeling that residual a complete GAAP gross profit would be misleading. Cost of goods sold increased 48.8%, faster than revenue, so the residual nonetheless identifies a question about mix and cost absorption that the next report should explain.

Nine-month operating cash use increased to $73.377M from $42.773M a year earlier. That deterioration matters even though adjusted operating loss improved. Compensation can increase reported operating cash relative to GAAP loss because it is noncash at issuance, while working-capital needs consume actual cash. Free cash flow here subtracts cash purchases of property and equipment; it does not add back the economic cost of dilution or claim that adjusted EBITDA is spendable money.

Current disclosure controls were effective at September 30. Historical warrant-exchange, filing-delay and amendment flags were separately reviewed and do not establish an unresolved current reporting problem. Our quality assessment concerns economics and comparability, not an allegation of misstatement. We also prioritize the final 10-Q over the preliminary release where balances differ: current assets and liabilities are each $3M lower, leaving equity, cash and debt unchanged.

Source: Final statements, cash flows and controls. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

Financing bought time, not profitability

Unrestricted cash was $134.249M at September 30, with an additional $10.023M restricted cash. Current and long-term debt carrying values totaled $429.998M, leaving $295.749M net debt on this defined basis. The $441.076M contractual debt-payment total is a different measure because carrying amounts include discounts and issuance costs. Our valuation uses carrying net debt consistently and identifies that convention instead of mixing one debt definition with another.

Nine-month free cash flow was negative $80.410M: operating outflow of $73.377M less $7.033M property and equipment spending. Dividing unrestricted cash by the average monthly outflow produces about fifteen months. This is a static stress illustration, not management runway guidance or a liquidity forecast. It ignores the timing of working-capital reversal, minimum cash needs, debt obligations, acquisitions, sale proceeds, taxes and future financing. The next cash bridge is more useful than presenting that ratio as a countdown.

Financing supplied $71.374M net cash over nine months. The company raised net proceeds from the 2031 notes, repurchased much of the 2027 notes, borrowed at Wuxi and received approximately $8.6M through its equity ATM. Extending debt maturities can reduce near-term refinancing pressure while still leaving interest, dilution and principal obligations. Issuing shares at a low price may preserve the operating business but reduce existing shareholders' participation in a later recovery.

The pending Wuxi sale contemplates roughly $135M gross consideration for the 34.38% stake, before applicable local taxes and closing conditions. The CMOS purchase totals €40M: €35M cash at closing, subject to adjustments, and a €5M vendor note with 2.5% simple interest due after twenty-four months. Regulatory approvals arrived November 4, but the November 6 filing says the acquisition had not closed. We do not subtract one proposed transaction from the other and call the result available liquidity.

Source: Cash flow, debt and transaction notes. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

Value the owners, not just the consolidated sales

All three routes use the existing consolidated perimeter, including Wuxi, and exclude the unclosed CMOS business. We add no future Wuxi sale cash. Instead, we estimate outside Wuxi owners' equity at $257.466M: the proposed $134.893M value for 34.38% divided by that stake and multiplied by the remaining 65.62%. This proportional transaction-price proxy is uncertain; control, taxes, terms and transfer restrictions can make another ownership block worth a different amount. It is an explicit approximation, not an assertion of a traded minority price.

ADK unit exchanges enter the 250M share count, which is above the November 3 combined Class A and V count of 240.797M. We do not also subtract ADK minority book equity, which would charge twice for those conversions. The Wuxi deduction addresses a separate ownership interest. At $1.81, modeled equity is $452.5M; adding $295.749M net debt and $257.466M external Wuxi equity yields about $1,005.715M operating value. Against the sales-route $300M revenue assumption, that is 3.35 times sales.

The 250M assumption includes ADK exchanges and an ordinary equity-issuance reserve, not every contingent share. Published $0/$1/$3 cases keep notes as debt for eventual cash settlement, assume no note conversion or Wuxi exchange, and preserve current Wuxi ownership. Those values are below initial note conversion prices, but future price paths, make-whole events and settlement elections can change the branch. Keeping debt in the bridge recognizes the claim; it does not establish that cash repayment is funded.

The final 10-Q discloses $170.5M principal of 2031 notes at an initial 258.3312 shares per $1,000 (about $3.87), and $218.5M of 2029 notes at 194.6188 (about $5.14). Gross initial-rate conversion adds 44.045M and 42.524M shares respectively. Company election permits cash, shares or a mix, subject to contractual conditions. The 2029 capped calls can offset dilution or cash payments above principal, subject to an initial $8.06 cap, counterparty performance and other terms; we assume no 2031 hedge. The remaining $26M 2027 notes initially convert around $8.65.

An illustrative high-value branch uses $2.5B operating value, converts the two larger issues, releases their $378.149M combined carrying amount consistently with our carrying-debt bridge, and adds 86.570M gross shares. ($2,500M − $295.749M + $378.149M − $257.466M) / 336.570M = about $6.91. It assumes no capped-call benefit, no make-whole increase, no Wuxi exchange and no 2027 conversion. It is not an additional probability-weighted target. Actual settlement requires fresh debt and call valuation; subtracting full debt while adding all converted shares would double-count the same claim.

A separate Wuxi branch matters. FY2025 10-K note 13 describes the November 2022 CNY300M raise: investors received 16% of Wuxi at issuance, with liquidation preferences and a conditional exchange right if no IPO by December 31, 2027. The exchange uses capital plus an 8% annual simple premium through that date, FX and INDI price at exchange, capped at six million Class A shares. This applies to the subscribed block, not all outside Wuxi ownership; its present percentage and fair value are not established here. Final 10-Q note 16 says sale completion releases that obligation because the qualifying investors tender into publicly traded Chinese equity.

If the exchange occurs, the branch is (operating value − net debt − outside-owner proxy + value of Wuxi block received) / (250M + INDI shares issued). Credit the block transferred to indie while adding issued shares. Do not retain its full outside-owner deduction as well. At base operating value $803.215M and the six-million-share cap, assumed received-block values of $0M/$15M/$30M/$45M produce $0.98/$1.04/$1.09/$1.15. These are sensitivities, not block-value estimates; $0 is a conservative input and liquidation preferences complicate valuation. A sale instead removes Wuxi economics and debt, adds actual net proceeds, and releases the exchange obligation. Neither alternative is silently embedded in the published probabilities.

The DCF assumes consolidated free cash to the firm of negative $30M, zero, $35M, $65M, $95M and $130M in 2027 through 2032. These are ambitious author assumptions after economic compensation, reinvestment and taxes, not a forecast inferred from design wins. At a 14% discount rate and 3% terminal growth, explicit cash flows are worth $144.360M and terminal value $554.573M. Deducting net debt and the outside-owner proxy leaves $0.58 per modeled share. Most operating value arrives beyond the explicit forecast, so small long-term changes have large effects.

The sales route assumes $300M of annual revenue at three times sales, giving $900M enterprise value and $1.39 per share after the same deductions. It is a current valuation convention using a forward revenue assumption, not another promised issuer target. The mature-earnings route assumes $600M revenue in 2031, a 20% operating margin and fifteen times EBIT, discounts the resulting $1.8B operating value for five years at 14%, and produces $1.53 per share. It assumes strong execution and does not mistake today's adjusted loss for mature earnings.

Weighting the DCF 50% and each cross-check 25% gives $1.02, rounded to $1.00. At the reference price, holding the explicit DCF cash flows unchanged would require approximately the terminal cash generation shown below; that reverse calculation is a hurdle, not proof the market actually uses our model. Very high uncertainty warrants a conditional 30% safety discount from the rounded base, or $0.70. A lower price would still need a fresh financing and transaction review before supporting a positive rating.

Source: Debt note 7 and subsequent-events note 16, page 32; author valuation branches. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

Source: Note 13: Wuxi capital raise and conditional exchange terms. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

A higher target is a competing thesis

The saved provider target aggregate is $4.50, with a $4 to $5 range. Its ratings snapshot contains seven buys and two holds. That is a clear contrast with our $1.00 value and SELL rating, but the aggregate does not make every underlying research note equally current. The most recent saved target item is B. Riley at $4 on November 6; Roth's $5 item dates to August 7, while the saved UBS $4.75 item dates to May 8. Dates and firm names matter more than an undated average.

The bullish interpretation is that design wins and the current core acceleration imply a much larger profitable business, while the Wuxi transaction supplies funding and simplifies the story. That is plausible. Our disagreement is about the amount of owner cash required to justify the current price after debt, outside economic interests and additional shares. If analysts use a different future business perimeter or faster profitability path, their targets can differ greatly without either side making an arithmetic error.

Provider revenue estimates average $266.586M for 2026, $354.717M for 2027 and $458.401M for 2028, with six analysts contributing the 2027 revenue estimate and five contributing 2028. Those are mixed-source provider estimates, not signed company commitments. The 2026 number falls inside the full-year range implied by the current quarterly guidance. Our sales-route $300M assumption is below the 2027 consensus, deliberately reserving for perimeter changes and uncertain conversion of wins to deliveries.

The source does not establish which future estimates already incorporate the Wuxi disposal or CMOS acquisition. We therefore do not calculate a precise like-for-like consensus growth surprise across those transactions. Likewise, the aggregate profit fields are not presented as GAAP earnings forecasts verified against every analyst's adjustments. Readers should ask for the cash bridge, ownership basis and fully diluted denominator behind any attractive target, including ours.

Source: Saved target news, ratings and annual estimates. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

Grade the conversion, not the vocabulary

Management deserves credit for a quarter that exceeded its revenue midpoint, a sequential core recovery and a lower adjusted operating loss. The stated product wins also provide concrete commercial evidence beyond a generic market-growth narrative. The release's emphasis on Physical AI broadens the addressable opportunity, but terminology alone does not establish a different financial model. Automotive and emerging robotics programs still need qualifications, shipping volumes, realized pricing and collections.

Capital allocation is harder to grade positively while cash consumption rises. The debt refinancing extended the funding structure, yet the company also raised equity and is pursuing an acquisition before achieving sustained cash generation. Neither decision is automatically wrong: a timely technology asset can improve long-term competitiveness, and refinancing can be prudent. The relevant question is whether the incremental program economics exceed the full cost of debt, shares and integration, with enough liquidity left for the existing portfolio.

The annual filing identifies KPMG as auditor and discloses a remaining $42.596M repurchase authorization at year end, with no common-stock repurchases in 2024 or 2025. Authorization is not an obligation or evidence that repurchases are the current best use of cash. A company consuming cash while borrowing and issuing shares should be evaluated on funding resilience, not on the size of a dormant authorization. Class V voting rights and ADK unit exchange rights also belong in any discussion of public-shareholder participation.

We would ask management five specific questions: how much Q4 growth is shipment timing rather than sustained demand; how inventory converts into cash by program; what compensation-adjustment components explain the difference from the GAAP note; what actual net liquidity will remain after both transactions; and what fully diluted share count investors should use through the profitability ramp. Answers should reconcile to filed numbers. Until then, successful product announcements earn operating credit but do not remove the valuation discount.

Source: Annual structure and capital allocation; current release and 10-Q. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

The downside and the best counterargument

The highest risk is that the profitable scale point remains farther away than the cash balance can comfortably support. Cash burn and dilution can create a feedback loop: a weak share price makes equity funding more expensive, while a larger share count reduces each old share's recovery value. Debt can bridge timing but also raises fixed claims. This does not imply imminent insolvency; it means the equity is a residual claim whose sensitivity deserves explicit attention.

Automotive program risk is next. A design selection can be delayed, resized or displaced by changes in vehicle production, customer requirements or competing technologies. The filing reports one customer at 12% of both quarterly and nine-month revenue, versus no customer above 10% in the comparable 2025 periods. Customer concentration and regional exposure can amplify what initially looks like a modest program delay. Manufacturing remains dependent on outsourced partners and the availability of components and capacity.

Transaction uncertainty affects both growth and funding. The Wuxi sale is subject to closing conditions and approvals, and the expected gross consideration is not guaranteed net cash. A completed sale removes an economic asset as well as providing proceeds. The CMOS business brings a cash payment, vendor debt, integration and new operating requirements. Our existing-perimeter model avoids booking either transaction prematurely, but it will become obsolete when an actual closing changes the financial position.

The strongest bull argument is that today's cost base is supporting a portfolio whose revenue is about to scale much faster. If the core sustains its guided growth, design wins turn into high-volume programs, inventory converts and the company funds the transition without excessive dilution, mature cash generation can greatly exceed our base. The $3 bull case acknowledges that possibility. The bear case is equally coherent: ongoing adjustments obscure persistent cash losses, the transaction path disappoints, and new capital absorbs most of the upside. Our SELL weighs the price paid today against those asymmetric financing claims.

Source: Risk factors, concentration and transaction terms. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

What can change the call

The next decisive event is the Q4 results package, which we will review by the end of February 2027; that date is an analytical checkpoint, not a confirmed announcement appointment. Consolidated revenue should be tested against the $73M lower guide and core revenue against the $47M midpoint, with any disposal or acquisition perimeter change explained first. A clean operating bridge matters more than celebrating a revenue beat that comes from buying another business or shifting shipment timing.

Cash flow will determine whether the operating recovery is becoming financially self-supporting. Our first quarterly threshold is operating cash outflow no worse than $15M, compared with the nine-month average near $24.5M. We also want unrestricted cash to remain at least $100M before separately identified deal movements. Those thresholds are not promises or hard covenants. They are falsifiable markers that allow readers to see whether our concern is being addressed instead of letting the thesis drift after the fact.

The transaction closings could rapidly change the analysis. For Wuxi, we need the actual net proceeds, removed assets and liabilities, remaining commitments and reporting basis. For CMOS, we need the closing payment, vendor-note terms, acquired revenue and profit baseline, and integration costs. We would rebuild the model from those disclosures; we would not merely add sale proceeds to the same consolidated business value and retain every sold revenue dollar.

A price below $0.70 is only a safety reference within today's assumptions. It would not automatically produce a BUY if the cash position, dilution or program outlook deteriorated. Conversely, better demonstrated owner cash can raise fair value even if the share price has already risen. The purpose of the checkpoints is to make the research responsive to evidence while keeping the original judgment visible. This first packet establishes that baseline for the next exact-quarter review.

Source: Q4 outlook; dates beyond issuer disclosures are author monitoring deadlines. Derived values are calculated in the retained dataset; valuation inputs are author assumptions.

Methods, history and sources

The historical tables use nine quarters of issuer earnings exhibits, with complete statement and reconciliation rows retained in the source dataset. The final November 6 10-Q governs the current balance sheet and cash flow. The annual cash-flow history comes from the 2025 Form 10-K's three-year statements. FMP supplies market prices, Street estimates and additional standardized history; its classification of costs can differ from the issuer, so it does not override the filed statements.

Dollar amounts are in millions unless a table specifies per-share values. Derived percentages use unrounded inputs. Free cash flow means operating cash flow less cash purchases of property and equipment. FCFF in the valuation is a separate author forecast of unlevered economic cash after reinvestment and compensation; it is not a claim that the historical FCF definition has already become positive. Working-capital days use ending balances and a ninety-day quarter as explicitly labeled proxies.

Non-GAAP adjustments are reported as management defines them, while GAAP amounts remain visible. The issuer does not report a GAAP gross margin; we do not invent one. Product-family revenue, product-family profit, future acquisition contribution and precise transaction-tax proceeds are not guessed when they are unavailable. The Wuxi minority proxy is a valuation assumption derived from a proposed stake price, not an audited fair value or book-equity substitute. Uncertainty in that proxy is material to every route.

The $1.00 base is a rounded present-value reference; the $0–$3 range is a scenario range, not a confidence interval. The $1.25 weighted value is the probability-weighted average of those scenarios and is intentionally distinct from the base. The annual reports show approximately 900 employees in 2023, 920 in 2024 and 800 in 2025. The tax receivable agreement assigns 85% of certain tax benefits to specified ADK holders; the model does not credit shareholders with the full value of an incremental tax shield. All valuation references are dated November 8, 2026. Neither the share price nor a long-term forecast is guaranteed. Later filings, financing, closing terms and product execution can change the conclusion, and the source files preserve what was known for this episode.